Logo image
GCN2 in Cancer: Molecular Mechanisms to Therapeutic Potential
Journal article   Peer reviewed

GCN2 in Cancer: Molecular Mechanisms to Therapeutic Potential

Hayley Prescott, Makhdoom Sarwar, Martin Dickens and Evelyn Sattlegger
Current cancer drug targets, Vol.26(3), pp.269-288
29/01/2025
Handle:
https://hdl.handle.net/10523/44928

Abstract

GCN2 Israel cancer EIF2AK4 anti-cancer treatment protein kinase integrated stress response
Virtually every mammalian cell contains the cytoplasmic protein kinase General Control Non-depressible 2 (GCN2), which allows cells to cope with stresses such as nutrient shortage. While GCN2 is not essential for normal cells, in many can-cers GCN2 assumes a pivotal role, becoming indispensable for cell growth and sur-vival. This has spurred significant interest in GCN2 as a promising target for anti-cancer therapies. In this review, we give an overview of the known links between GCN2 and cancer.

Metrics

36 Record Views

Details

Logo image